Basal and Isoprenaline-Stimulated cAMP Content in Failing Versus Nonfailing Human Cardiac Preparations
- 1 July 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 14 (1) , 171-173
- https://doi.org/10.1097/00005344-198907000-00026
Abstract
We measured force of contraction and cAMP content in human isolated electrically driven right ventricular trabeculae carneae with and without the addition of isoprenaline (0.2 μM). Basal cAMP content was ∼200% higher in preparations from nonfailing hearts than from hearts with end-stage myocardial failure. Isoprenaline was less effective in increasing force of contraction in failing (by ∼100%) than in nonfailing cardiac preparations (by ∼500%). With isoprenaline, cAMP content was ∼50% lower in failing than in nonfailing preparations. We conclude that the reduced increase in force of contraction of failing human cardiac preparations with isoprenaline added may be causally related to an inadequately increased cAMP content.This publication has 4 references indexed in Scilit:
- INCREASE IN MYOCARDIAL Gi-PROTEINS IN HEART FAILUREThe Lancet, 1988
- THE ROLE OF CYCLIC-AMP IN THE POSITIVE INOTROPIC EFFECT MEDIATED BY BETA-1- AND BETA-2-ADRENOCEPTORS IN ISOLATED HUMAN RIGHT ATRIUM1987
- Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.Circulation, 1987
- The positive inotropic response to milrinone in isolated human and guinea pig myocardiumNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1986